<html>
<head>PUBMED IDs for TIC1</head>
<body bgcolor='#C5F0F2'><h1>TIC1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19376178/'>Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates.</a> October 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23390247/'>Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.</a> January 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25189227/'>Quantitative trait loci analysis of individual and total isoflavone contents in soybean seeds.</a> April 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25189222/'>Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up.</a> November 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25189219/'>Discovery and validation of novel microRNAs in Sjögren's syndrome salivary glands.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25681273/'>Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.</a> August 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25712124/'>Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.</a> January 24  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25927855/'>Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway.</a> February 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26580220/'>First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent.</a> June 18  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26884600/'>ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases.</a> November 11  2016<br></body></html>
